Unichem Laboratories spikes post zero observation from USFDA
Unichem Laboratories spikes post zero observation from USFDA

Unichem Laboratories spikes post zero observation from USFDA

Amir Shaikh Article rating: 5.0

On the first trading session of the week, the stock of Unichem Laboratories surged more than 8 per cent due to zero observation from US Food and Drug Administration (USFDA).

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 69.67 lakh contracts with a turnover of Rs. 5,87,393.11 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 69.67 lakh contracts with a turnover of Rs. 5,87,393.11 crore.

Index trend and stocks in action April 23, 2018
Index trend and stocks in action April 23, 2018

Index trend and stocks in action April 23, 2018

DSIJ Intelligence-3 Article rating: 5.0

Going ahead, holding on to the low of 10,495, which was made on April 17, would maintain a positive bias and keep the index on course to retest the swing high of 10632 registered on February 27. Stocks in the news: Unichem Laboratories, Adani Enterprises, Kitex Garments, Axis Bank, Orchid Pharma, Cimmco, Aro Granite, Dilip Buildcon, Phoenix Mills and Suzlon Energy.

Building an emergency fund
Building an emergency fund

Building an emergency fund

DSIJ Intelligence Article rating: 5.0

It is imperative that every household has an emergency fund that can take care of expenses arising out of any emergency situation, such as hospital bills, loss of job and unexpected household expenses.

Investing in bonds
Investing in bonds

Investing in bonds

DSIJ Intelligence Article rating: 5.0

If you are a retired person or a risk-averse individual looking for steady return over the long term, you should consider investing in bonds issued by the government or by corporate entities. Investments in bonds provide steady income to the investor in the form of interest payments at regular intervals. 

RSS
First37983799380038013803380538063807Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR